These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 3008324)
21. Long-term renal effects of enalapril therapy in patients with renal insufficiency. Smith RD; Rodel PV; Mulcahy WS; Price BA Nephron; 1990; 55 Suppl 1():49-58. PubMed ID: 2189074 [TBL] [Abstract][Full Text] [Related]
22. Different effects of two angiotensin converting enzyme inhibitors in primary hypertension--a comparison of captopril and enalapril. Karlberg BE; Sjöstrand A; Ohman KP J Hypertens Suppl; 1986 Dec; 4(5):S432-4. PubMed ID: 3033182 [TBL] [Abstract][Full Text] [Related]
23. Enalapril: antiproteinuric effect in children with nephrotic syndrome. Lama G; Luongo I; Piscitelli A; Salsano ME Clin Nephrol; 2000 Jun; 53(6):432-6. PubMed ID: 10879662 [TBL] [Abstract][Full Text] [Related]
24. Comparison of the free radical scavenging activity of captopril versus enalapril: a three month in vivo study in hypertensive diabetic patients. Bain SC; Le Guen CA; Lunec J; Barnett AH J Hum Hypertens; 1991 Dec; 5(6):511-5. PubMed ID: 1791611 [TBL] [Abstract][Full Text] [Related]
25. Influence of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome. Tesar V; Zima T; Jirsa M; Crkovská J; Stípek S; Vernerová Z; Seráková M Med Sci Monit; 2002 Feb; 8(2):BR69-74. PubMed ID: 11859270 [TBL] [Abstract][Full Text] [Related]
26. The progression of adriamycin-induced nephrotic syndrome in rats and the effect of captopril. Hall RL; Wilke WL; Fettman MJ Toxicol Appl Pharmacol; 1986 Jan; 82(1):164-74. PubMed ID: 3511565 [TBL] [Abstract][Full Text] [Related]
27. [Evaluation of captopril-enalapril replacement therapy in hypertensive patients under ambulatory blood pressure monitoring]. Ruszty L; Hidas I; Iványi J; Dudás M; Molnár S Orv Hetil; 1996 Dec; 137(51):2851-4. PubMed ID: 9679620 [TBL] [Abstract][Full Text] [Related]
28. Effect of enalapril on proteinuria after kidney transplantation. Rell K; Linde J; Morzycka-Michalik M; Gaciong Z; Lao M Transpl Int; 1993; 6(4):213-7. PubMed ID: 8347267 [TBL] [Abstract][Full Text] [Related]
29. Tolerability of long term therapy with enalapril maleate in patients resistant to other therapies and intolerant to captopril. Rucinska EJ; Small R; Mulcahy WS; Snyder DL; Rodel PV; Rush JE; Smith RD; Walker JF; Irvin JD Med Toxicol Adverse Drug Exp; 1989; 4(2):144-52. PubMed ID: 2541310 [TBL] [Abstract][Full Text] [Related]
30. Tolerance and safety of enalapril. McFate Smith W; Davies RO; Gabriel MA; Kramsch DM; Moncloa F; Rush JE; Walker JF Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):249S-253S, 255S. PubMed ID: 6099740 [TBL] [Abstract][Full Text] [Related]
31. Mortality associated with captopril and enalapril: a report from the DHSS Hypertension Care Computing Project. Palmer AJ; Beevers DG; Bulpitt CJ; Butler A; Coles EC; Conway J; Fletcher AE; Ledingham JG; Nicholls A; O'Riordan PW J Hypertens; 1990 Jun; 8(6):521-4. PubMed ID: 2165086 [TBL] [Abstract][Full Text] [Related]
32. The effect of enalapril on nephrotic proteinuria and determination of serum angiotensin-converting enzyme before and after treatment. Bianchini G; Letizia C; Domenici A; Scavo D Drugs Exp Clin Res; 1991; 17(5):263-9. PubMed ID: 1661665 [TBL] [Abstract][Full Text] [Related]
33. Pathophysiology of experimental nephrotic syndrome induced by puromicyn aminonucleoside in rats. III. Effect of captopril, an angiotensin converting enzyme inhibitor, on proteinuria and sodium retention. Pedraza-Chaverrí J; Cruz C; Chávez MT; Ibarra-Rubio ME; Tapia E; Peña JC Rev Invest Clin; 1990; 42(3):210-6. PubMed ID: 2270368 [TBL] [Abstract][Full Text] [Related]
35. Intra-individual comparison of captopril and enalapril in patients undergoing regular haemodialysis. Sennesael J; Verbeelen D Eur J Clin Pharmacol; 1986; 30(3):257-62. PubMed ID: 3015637 [TBL] [Abstract][Full Text] [Related]
36. Comparison of captopril and enalapril in patients with severe chronic heart failure. Packer M; Lee WH; Yushak M; Medina N N Engl J Med; 1986 Oct; 315(14):847-53. PubMed ID: 3018566 [TBL] [Abstract][Full Text] [Related]
37. [Effect of enalapril in patients with essential hypertension]. Wang X Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Apr; 18(2):79-81, 126. PubMed ID: 2209407 [TBL] [Abstract][Full Text] [Related]
38. Eplerenone potentiates the antiproteinuric effects of enalapril in experimental nephrotic syndrome. Nakhoul F; Khankin E; Yaccob A; Kawachi H; Karram T; Awaad H; Nakhoul N; Hoffman A; Abassi Z Am J Physiol Renal Physiol; 2008 Mar; 294(3):F628-37. PubMed ID: 18094029 [TBL] [Abstract][Full Text] [Related]
39. Comparison of captopril and enalapril in the treatment of hypertension in patients with non-insulin dependent diabetes mellitus and nephropathy. Cheng IK; Ma JT; Yeh GR; Chan MK Int Urol Nephrol; 1990; 22(3):295-303. PubMed ID: 2210987 [TBL] [Abstract][Full Text] [Related]
40. Side effect of captopril and enalapril. Rossetto BJ West J Med; 1987 Jan; 146(1):102. PubMed ID: 3030007 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]